Could it be time to consider buying CSL shares?
A number of Australia’s leading brokers have given their verdict on the CSL share price in recent months. And as you might expect due to COVID-19 uncertainties, opinion is largely divided on whether now is a good time to consider buying CSL shares.
Below is a summary of what brokers are saying about CSL shares in July 2021.
Citi
Citi currently has a neutral rating and $310.00 CSL share price target. This implies potential upside of 11% over the next 12 months. Citi is also forecasting a CSL dividend of $3.14 per share in FY 2021.
Goldman Sachs
Goldman Sachs has a neutral rating and CSL share price target of $305.00. If CSL shares hit this level, it will mean a gain of 9.2%. In addition, Goldman has pencilled in a CSL dividend of $2.81 this year.
Morgans
Morgans currently has an add rating and CSL share price target of $301.10. This represents a potential return of 7.9%. The broker is also forecasting a CSL dividend of $2.86 per share in FY 2021.
UBS
UBS is the most bullish broker with a buy rating and CSL share price target of $330.00. This implies potential upside of 18.2% over the next 12 months. UBS’ analysts are forecasting a CSL dividend of ~$2.33 per share in 2021.
Broker comments
The team at Goldman Sachs explained why they are neutral on the CSL share price.
Goldman said: “We are Neutral rated on CSL. Our 12-month TP of A$305 is based on our target NTM EV/EBITDA multiple of 28.9x. Key upside risks include: (1) Faster-than-expected recovery in plasma collections; (2) More supportive pricing dynamic than we already expect; (3) Positive results from the pipeline. Key downside risks include: (1) Extent of disruption to plasma collections; (2) Threat of mRNA/competitive approaches to Seqirus vaccine business; (3) Competitive product launches; (4) Plasma donor fee inflation.”
- Forums
- ASX - By Stock
- CSL
- Could it be time to consider buying CSL shares ?
Could it be time to consider buying CSL shares ?
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$278.20 |
Change
-3.760(1.33%) |
Mkt cap ! $134.4B |
Open | High | Low | Value | Volume |
$279.50 | $280.30 | $278.20 | $220.7M | 791.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 12008 | $278.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$278.31 | 35 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 278.150 |
1 | 1000 | 278.110 |
1 | 300 | 278.070 |
1 | 2487 | 278.040 |
1 | 12 | 278.030 |
Price($) | Vol. | No. |
---|---|---|
278.310 | 35 | 1 |
279.620 | 1007 | 2 |
279.760 | 80 | 1 |
279.780 | 1007 | 1 |
279.820 | 2487 | 1 |
Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
Last
$279.07 |
  |
Change
-3.760 ( 0.97 %) |
|||
Open | High | Low | Volume | ||
$279.78 | $280.29 | $279.03 | 107046 | ||
Last updated 15.59pm 29/05/2024 ? |
Featured News
CSL (ASX) Chart |